Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c00964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Rui Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, Shenyang110167, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, Shenyang110167, China.
- State Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai201203, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai264117, Shandong, China.
ORCID-Profile: Rui Cao, Hongguang Liu, Zhen Cheng
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Cao, R., Li, R., Shi, H., Liu, H., & Cheng, Z. (2023). Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c00964
Vancouver
Cao R, Li R, Shi H, Liu H, Cheng Z. Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c00964
BibTeX
@article{Cao2023,
author = {Cao, Rui and Li, Renda and Shi, Hui and Liu, Hongguang and Cheng, Zhen},
title = {Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c00964}
}
EUVIMED